High-grade liver injuries with extravasation (HGLI + Extrav) are associated with morbidity/mortality. For low-grade injuries, an observation (OBS) first-strategy is beneficial over initial angiography (IR), however, it is unclear if OBS is safe for HGLI + Extrav. Therefore, we evaluated the management of HGLI + Extrav patients, hypothesizing IR patients will have decreased rates of operation and mortality. HGLI + Extrav patients managed with initial OBS or IR were included. The primary outcome was need for operation. Secondary outcomes included liver-related complications (LRCs) and mortality. From 59 patients, 23 (39.0%) were managed with OBS and 36 (61.0%) with IR. 75% of IR patients underwent angioembolization, whereas 13% of OBS patients underwent any IR, all undergoing angioembolization. IR patients had an increased rate of operation (13.9% vs. 0%, p = 0.049), but no difference in LRCs (44.4% vs. 43.5%) or mortality (5.6% vs. 8.7%) versus OBS patients (both p > 0.05). Over 60% of patients were managed with IR initially. IR patients had an increased rate of operation yet similar rates of LRCs and mortality, suggesting initial OBS reasonable in appropriately selected HGLI + Extrav patients.
The incidence of pediatric gallstone disease continues to rise, largely driven by increasing obesity rates. Laparoscopic cholecystectomy (LC) has been the standard surgical approach, with robotic-assisted cholecystectomy (RAC) utilized less frequently. This study aimed to evaluate the implementation of RAC and its outcomes compared to LC at a single institution. A retrospective cohort study was conducted of all pediatric cholecystectomies at our children's hospital from 2017 through 2024. Surgical outcomes were abstracted. Statistical tests were employed, with p < 0.05 considered significant. During the study, 420 cholecystectomies were performed: 196 LC and 224 RAC. Median age was 15.5 years, median BMI was 28.1 kg/m2, and 75 % of patients were female. The most common diagnoses were choledocholithiasis (179) and symptomatic cholelithiasis (135). Yearly cholecystectomies increased. LC was performed more often for urgent cases (p < 0.01). RAC was used more often in patients with obesity and severe obesity (p = 0.01). Median operative time slightly differed between LC and RAC (11 min; p < 0.01). There was one conversion to open (LC) and nine retained common duct stones. There was no difference in emergency department revisits (7.7 % LC vs 6.7 % RAC; p = 0.69) or readmissions (2.6 % LC vs 3.1 % RAC; p = 0.73). There were no bile leaks, common bile duct injuries or mortalities. In this largest reported cohort of pediatric RAC, RAC was found to be safe and effective compared with LC, particularly in pediatric patients with obesity. RAC can be integrated into practice without compromising patient safety. Further research evaluating educational and fiscal aspects of RAC is ongoing.
5 August 2025 in World Journal of Pediatric Surgery
Background: Necrotizing enterocolitis (NEC) is associated with increased neurodevelopmental impairment. Gut-brain interactions through the brainstem may be central to NEC-related microglia-driven neuroinflammation. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) has intestinal protective properties and is a potential therapy for NEC. The aim of this study is to test the hypothesis that HB-EGF in pregnant rats reduces both NEC incidence and proinflammatory changes in the brainstem microglia of newborn rats. Methods: We compared four experimental groups, HB-EGF + /NEC – , HB-EGF – /NEC – , HB-EGF + /NEC + and HB-EGF – /NEC + , depending on whether HB-EGF was given prenatally, and whether the newborn rats underwent the NEC induction protocol. We stained brainstem microglia and performed fractal analyses to provide objective measures of morphological changes. Results: NEC incidence was lower in the HB-EGF + /NEC + group ( n =64, p <0.005) than in the HB-EGF – /NEC + group. Brainstem microglia of breastfed rats had a larger cell area, perimeter, roughness, and less circularity compared with smaller, denser, compact cells in the NEC + pups ( p <0.0001, n =320 cells). HB-EGF + /NEC + and HB-EGF – /NEC + pups had similar-appearing microglia. Conclusions: Prenatal HB-EGF treatment reduces NEC incidence in neonatal rats. NEC-related proinflammatory changes are seen in microglial cells present in crucial centers controlling the gut-brain pathway. HB-EGF has a growth-promoting effect on healthy microglia in the offspring but does not avert microglial activation in the brainstem of newborn rats with NEC.